Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors / Nuñez, Ng; Berner, F; Friebel, E; Unger, S; Wyss, N; Gomez, Jm; Purde, Mt; Niederer, R; Porsch, M; Lichtensteiger, C; Kramer, R; Erdmann, M; Schmitt, C; Heinzerling, L; Abdou, Mt; Karbach, J; Schadendorf, D; Zimmer, L; Ugurel, S; Klümper, N; Hölzel, M; Power, L; Kreutmair, S; Capone, M; Madonna, G; Cevhertas, L; Heider, A; Amaral, T; Hasan Ali, O; Bomze, D; Dimitriou, F; Diem, S; Ascierto, Pa; Dummer, R; Jäger, E; Driessen, C; Levesque, Mp; Van De Veen, W; Joerger, M; Früh, M; Becher, B; Flatz, L. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - (2023). [10.1016/j.medj.2022.12.007]

Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

Schmitt C;Ascierto PA;
2023

2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors / Nuñez, Ng; Berner, F; Friebel, E; Unger, S; Wyss, N; Gomez, Jm; Purde, Mt; Niederer, R; Porsch, M; Lichtensteiger, C; Kramer, R; Erdmann, M; Schmitt, C; Heinzerling, L; Abdou, Mt; Karbach, J; Schadendorf, D; Zimmer, L; Ugurel, S; Klümper, N; Hölzel, M; Power, L; Kreutmair, S; Capone, M; Madonna, G; Cevhertas, L; Heider, A; Amaral, T; Hasan Ali, O; Bomze, D; Dimitriou, F; Diem, S; Ascierto, Pa; Dummer, R; Jäger, E; Driessen, C; Levesque, Mp; Van De Veen, W; Joerger, M; Früh, M; Becher, B; Flatz, L. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - (2023). [10.1016/j.medj.2022.12.007]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1020352
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 109
  • ???jsp.display-item.citation.isi??? ND
social impact